Prakash S Nagarkatti

28PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Infectious agentsMedical virologyFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 11, 2026
Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

|Jan 28, 2026
VERU-111 Promotes an Anti-Tumor Response Through Restoration of Gut Microbial Homeostasis and Associated Metabolic Dysregulation.

Md Abdullah Al Mamun, Ahmed Rakib, Mousumi Mandal

|Feb 02, 2025
AhR Activation Transcriptionally Induces Anti-Microbial Peptide Alpha-Defensin 1 Leading to Reversal of Gut Microbiota Dysbiosis and Colitis.

Manikandan Palrasu, Khadija Kakar, Amarnath Marudamuthu

|Aug 29, 2024
Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.

Taylor H Carter, Chloe E Weyer-Nichols, Jeffrey I Garcia-Sanchez

|Feb 24, 2024
Aryl Hydrocarbon Receptor Regulates Muc2 Production Independently of IL-22 during Colitis.

Archana Saxena, Chandani Mitchell, Raymond Bogdon

|Nov 14, 2023
Resveratrol Attenuates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Induction of Myeloid-Derived Suppressor Cells (MDSC) and Their Functions.

Wurood Hantoosh Neamah, Alex Rutkovsky, Osama Abdullah

Pageof 5

Frequent Collaborators

22 joint publications

Mitzi Nagarkatti

6 joint publications

Kiesha Wilson

4 joint publications

Philip Brandon Busbee

3 joint publications

Wurood Hantoosh Neameh